[ad_1]
The European Commission recommended this Tuesday to the countries of the bloc that facilitate the resumption of traffic with the United Kingdomwhose isolation due to a new strain of the coronavirus wreaked havoc on its connections to the continent.
Brussels called for the resumption of “essential travel” to be facilitated for “Avoid breaks in the supply chain” and thus allow thousands of EU and UK citizens to return home.
France took a first step in this regard, when on Tuesday it announced that it will authorize, as of Wednesday, the return from the United Kingdom of those persons residing in France or in the European area, or that “they must make essential trips”, as long as they present a negative covid-19 test “of less than 72 hours”.
Germany, on the other hand, decided to extend “until January 6” andl closure of its borders with the United Kingdom and South Africa, where a variant of the virus also emerged.
WHO meeting on Wednesday
Due to the emergence of a SARS-CoV-2 mutation, some 50 countries suspended or restricted connections with the United Kingdom, which remained practically isolated.
Many travelers were left to their own devices after many countries decided to suspend their air connections, and some of them feared they would not be able to see their family for the New Year’s Eve holidays.
The EU is trying to harmonize the measures put in place by its members to prevent the UK variant of the virus from spreading, while the European division of the World Health Organization (WHO) is scheduled to meet on Wednesday morning to discuss the strategy on the continent.
And while several countries plan to start vaccination on Sunday, the German laboratory BioNTech, creator together with the US giant Pfizer of the first internationally approved vaccine against COVID-19, assured that it could supply, if necessary, “in six weeks” a vaccine adapted to the new strain of the virus registered in the UK.
All in all, the WHO tried to convey a reassuring message on Monday, noting that the new strain “It’s not out of control”, as the British Health Minister, Matt Hancock, had stated.
For its part, the European Medicines Agency (EMA), which on Monday gave its authorization to the Pfizer / BioNTech vaccine, said it was not “very concerned” and reiterated that there is “no evidence” that indicates that the treatment would not protect against this mutation of the virus.
[ad_2]
